Actively Recruiting

Age: 18Years - 80Years
MALE
Healthy Volunteers
NCT07403786

Urethral Resistive Index (URI): A New Parameter for Diagnosing Urethral Obstruction

Led by Ankara City Hospital Bilkent · Updated on 2026-04-06

60

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective observational study aims to evaluate the diagnostic accuracy of a new, non-invasive uroflowmetry parameter called the Urethral Resistive Index (URI) for detecting urethral stricture in men. Currently, diagnosing urethral stricture often requires invasive procedures like surgery or pressure-flow studies. This research seeks to develop URI as a practical and painless screening tool that could reduce the need for such invasive interventions. Study Procedures: A total of 60 male participants (30 with suspected urethral stricture and 30 healthy volunteers) will be enrolled. Participants will undergo two standard, non-invasive uroflowmetry (voiding) tests. The first test is a routine natural voiding session. The second test involves a "forced voiding" (Valsalva maneuver) once the participant feels a sufficient urge to urinate again. The URI is then calculated by comparing the flow rates of these two sessions. Goals and Benefits: The primary goal is to determine the optimal "cut-off" value of the URI that accurately identifies a surgically proven urethral stricture. By demonstrating URI's effectiveness, the study aims to expedite the diagnostic process and spare patients from unnecessary invasive tests. The procedure involves minimal risk, primarily temporary discomfort or psychological stress during the voiding tests

CONDITIONS

Official Title

Urethral Resistive Index (URI): A New Parameter for Diagnosing Urethral Obstruction

Who Can Participate

Age: 18Years - 80Years
MALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Male participants aged between 18 and 80 years
  • Patients scheduled for surgery due to suspected urethral stricture with diagnosis confirmed during surgery
  • Healthy male volunteers without lower urinary tract symptoms
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Voiding volume less than 150 mL
  • Obstruction caused by conditions other than stricture, such as Benign Prostatic Hyperplasia (BPH)
  • Diagnosis of neurogenic bladder dysfunction or history of neurological disease affecting bladder function
  • Presence of severe comorbidities

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ankara Bilkent City Hospital

Ankara, Universiteler, Turkey (Türkiye), 06800

Actively Recruiting

Loading map...

Research Team

Y

Yusuf Gökkurt

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here